EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Risk factors and choice of the treatment for uterine choriocarcinoma



Risk factors and choice of the treatment for uterine choriocarcinoma



Voprosy Onkologii (St Petersburg) 32(3): 23-27



An analysis of the results of uterine choriocarcinoma treatment versus the degree of risk is presented. Chemotherapy alone was found to be sufficient in 70.2% of cases free of risk, as compared with only 31.2% in case of four and more factors. Application of chemotherapy alone proved, on the whole, to be more beneficial than that of surgery plus chemotherapy modality, as evidenced by the death rates of 13.8 .+-. 3.4 and 32.5 .+-. 5.4% (t=2.9), respectively. Polychemotherapy of cases with 1-4 factors of risk or more gave significantly better results than monochemotherapy, regardless of the former being a sole treatment or a component of combined therapy.

(PDF 0-2 workdays service: $29.90)

Accession: 006345045

Download citation: RISBibTeXText



Related references

Risk factors and choice of treatment method with uterine choriocarcinoma patients. Voprosy Onkologii 32(3): 23-27, 1986

Risk factors in uterine choriocarcinoma and their influence on treatment results. Voprosy Onkologii (St Petersburg) 32(1): 64-70, 1986

Risk factors in uterine choriocarcinoma patients and their effect on the treatment results. Voprosy Onkologii 32(1): 64-70, 1986

Factors influencing long term results of uterine choriocarcinoma treatment. Voprosy Onkologii (St Petersburg) 31(7): 62-68, 1985

Factors affecting late treatment results with uterine choriocarcinoma patients. Voprosy Onkologii 31(7): 62-68, 1985

Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors. Annals of Oncology 23 Suppl 10: X173-X177, 2013

Re: "Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation". American Journal of Epidemiology 155(2): 187-188, 2002

Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. American Journal of Epidemiology 153(1): 11-19, 2001

Late pulmonary metastases of uterine choriocarcinoma: apropos of a case occurring 19 years after hysterectomy for choriocarcinoma. Review of the literature. Revue de Pneumologie Clinique 42(2): 104-109, 1986

The role of surgical interventions in the treatment of uterine choriocarcinoma. Akusherstvo i Ginekologiia: 40-42, 1988

The uterine choriocarcinoma in postmenopausal women: specificities of diagnosis and treatment. Pan African Medical Journal 19: 176-176, 2015

Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. 'Effective treatment' or 'not a natural choice'?. Human Reproduction 18(5): 912-914, 2003

Combined modality adjuvant treatment of high-risk rectal cancer: a treatment of choice or a choice of treatment?. Annals of Oncology 3(3): 197-199, 1992

Surgical treatment of inflammations of the uterine adnexa and risk factors. Ceskoslovenska Gynekologie 38(3): 167-168, 1973

Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial. Heart 95(6): 468-475, 2008